Drug Profile
Troxerutin - Inpharma SA
Alternative Names: IN-001; Troxerutine - Inpharma SA; Troxerutine topicalLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Inpharma SA
- Class Vascular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 18 Mar 2002 No development reported - Phase-III for Erectile dysfunction in France (Topical)
- 20 Jul 1999 New profile
- 20 Jul 1999 Phase-III clinical trials for Erectile dysfunction in France (Topical)